TME Pharma N.V. Working Capital to Net Assets Ratio
TME Pharma N.V. working capital to net assets ratio. TME Pharma N.V. (ALTME) has a Working Capital to Net Assets ratio of 101.1% as of December 2025. Working capital of €-1.60 Million (current assets of €2.12 Million minus current liabilities of €3.72 Million) is measured against net assets of €-1.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of TME Pharma N.V. to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of TME Pharma N.V. (2014–2025)
Working capital to net assets ratio of TME Pharma N.V. from 2014 to 2025. This chart shows how TME Pharma N.V.'s Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 101.1%, reflecting working capital of €-1.60 Million against net assets of €-1.58 Million EUR. See TME Pharma N.V. (ALTME) defensive interval to measure how many days the company can operate on defensive assets alone.
TME Pharma N.V. Working Capital to Net Assets Ratio by Year (2014–2025)
TME Pharma N.V. working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for TME Pharma N.V. from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ALTME asset base.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 101.1% | €-1.60 Million | €-1.58 Million | €2.12 Million | €3.72 Million | ▲ +3.7 pp |
| 2024 | 97.3% | €1.57 Million | €1.61 Million | €3.36 Million | €1.79 Million | ▼ -38.4 pp |
| 2023 | 135.7% | €-399.00K | €-294.00K | €2.39 Million | €2.79 Million | ▲ +22.9 pp |
| 2022 | 112.8% | €-1.44 Million | €-1.27 Million | €5.01 Million | €6.45 Million | ▲ +14.5 pp |
| 2021 | 98.3% | €4.43 Million | €4.50 Million | €9.69 Million | €5.27 Million | ▼ -0.8 pp |
| 2020 | 99.1% | €7.63 Million | €7.70 Million | €10.53 Million | €2.90 Million | ▼ -4.5 pp |
| 2019 | 103.6% | €-1.92 Million | €-1.85 Million | €1.58 Million | €3.50 Million | ▲ +5.3 pp |
| 2018 | 98.4% | €-2.56 Million | €-2.61 Million | €4.47 Million | €7.04 Million | ▲ +20.7 pp |
| 2017 | 77.7% | €-3.04 Million | €-3.92 Million | €871.00K | €3.92 Million | ▼ -25.6 pp |
| 2016 | 103.3% | €-2.56 Million | €-2.48 Million | €2.79 Million | €5.35 Million | ▲ +83.1 pp |
| 2015 | 20.2% | €-1.42 Million | €-7.03 Million | €5.36 Million | €6.78 Million | ▼ -29.6 pp |
| 2014 | 49.8% | €-3.11 Million | €-6.24 Million | €2.07 Million | €5.18 Million | — |